Nymox Pharmaceutical
NYMX
#10328
Rank
โ‚น1.68 B
Marketcap
Country
โ‚น18.49
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -โ‚น4.92

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น5.55. In 2022 the company made an earnings per share (EPS) of -โ‚น7.40 an increase over its 2021 EPS that were of -โ‚น13.87.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น4.92-33.51%
2022-โ‚น7.40-46.67%
2021-โ‚น13.87-11.76%
2020-โ‚น15.72-15%
2019-โ‚น18.495.26%
2018-โ‚น17.57-26.92%
2017-โ‚น24.04-7.14%
2016-โ‚น25.89-40.43%
2015-โ‚น43.46291.67%
2014-โ‚น11.10-7.69%
2013-โ‚น12.02-43.48%
2012-โ‚น21.27-25.81%
2011-โ‚น28.6755%
2010-โ‚น18.4925%
2009-โ‚น14.800.08%
2008-โ‚น14.78-11.12%
2007-โ‚น16.63-0.16%
2006-โ‚น16.6628.59%
2005-โ‚น12.96-12.49%
2004-โ‚น14.81-16.05%
2003-โ‚น17.6419.07%
2002-โ‚น14.8114.45%
2001-โ‚น12.94-22.16%
2000-โ‚น16.635.64%
1999-โ‚น15.74-34.59%
1998-โ‚น24.06-3.6%
1997-โ‚น24.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,030-18,664.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น125.76-2,366.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น346.80-6,350.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,129-38,474.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น820.24-14,883.33%๐Ÿ‡บ๐Ÿ‡ธ USA